Increased survival of glioblastoma patients who respond to antiangiogenic therapy with elevated blood perfusion.
about
Combination therapy in cancer: effects of angiogenesis inhibitors on drug pharmacokinetics and pharmacodynamicsVEGF pathway targeting agents, vessel normalization and tumor drug uptake: from bench to bedsideRemodeling Components of the Tumor Microenvironment to Enhance Cancer TherapyOverview of Methods for Overcoming Hindrance to Drug Delivery to Tumors, with Special Attention to Tumor Interstitial FluidCancer imaging by optical coherence tomography: preclinical progress and clinical potential.Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunitiesA conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma CareMechanisms of evasive resistance to anti-VEGF therapy in glioblastomaMetabolic and hypoxic adaptation to anti-angiogenic therapy: a target for induced essentialityBiphasic modeling of brain tumor biomechanics and response to radiation treatmentQuantitative ex-vivo micro-computed tomographic imaging of blood vessels and necrotic regions within tumors.Intraoperative intravital microscopy permits the study of human tumour vesselsEmerging Techniques in Brain Tumor Imaging: What Radiologists Need to KnowRelationship between hypoxia and response to antiangiogenic therapy in metastatic colorectal cancerRole and therapeutic potential of G-protein coupled receptors in breast cancer progression and metastasesAdult brain cancer in the U.S. black population: a Surveillance, Epidemiology, and End Results (SEER) analysis of incidence, survival, and trendsThe comprehensive neuro-oncology data repository (CONDR): a research infrastructure to develop and validate imaging biomarkersAntiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia.Opportunities and challenges for successful use of bevacizumab in pediatrics.Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors.Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers.Modeling of nanotherapeutics delivery based on tumor perfusion.Vessel caliber--a potential MRI biomarker of tumour response in clinical trials.Low incidence of pseudoprogression by imaging in newly diagnosed glioblastoma patients treated with cediranib in combination with chemoradiation.An efficient computational approach to characterize DSC-MRI signals arising from three-dimensional heterogeneous tissue structuresImaging biomarkers for antiangiogenic therapy in malignant gliomas.Advanced magnetic resonance imaging of the physical processes in human glioblastoma.ASFNR recommendations for clinical performance of MR dynamic susceptibility contrast perfusion imaging of the brain.Vascular measurements correlate with estrogen receptor statusThe role of mechanical forces in tumor growth and therapyIn vivo imaging of tumor physiological, metabolic, and redox changes in response to the anti-angiogenic agent sunitinib: longitudinal assessment to identify transient vascular renormalization.Magnetic resonance imaging identifies early effects of sunitinib treatment in human melanoma xenografts.MR imaging assessment of tumor perfusion and 3D segmented volume at baseline, during treatment, and at tumor progression in children with newly diagnosed diffuse intrinsic pontine gliomaCombined efficacy of cediranib and quinacrine in glioma is enhanced by hypoxia and causally linked to autophagic vacuole accumulation.Bevacizumab treatment induces metabolic adaptation toward anaerobic metabolism in glioblastomasVideo-rate resonant scanning multiphoton microscopy: An emerging technique for intravital imaging of the tumor microenvironmentHypervascular tumor volume estimated by comparison to a large-scale cerebral blood volume radiographic atlas predicts survival in recurrent glioblastoma treated with bevacizumab.Systems pharmacology approaches for optimization of antiangiogenic therapies: challenges and opportunities.Parametric response maps of perfusion MRI may identify recurrent glioblastomas responsive to bevacizumab and irinotecan.Vascular normalization induced by sinomenine hydrochloride results in suppressed mammary tumor growth and metastasis
P2860
Q26746067-F365C4FD-0ED8-4374-87FD-411C4799F32CQ26770678-7301CD46-50B3-4473-9203-33C05E618937Q26777144-4B00FB4F-B7E0-47BA-8D87-5330353B5032Q26799981-87E03DD5-7106-4693-82DD-1B275F997701Q26823084-38D07607-FE52-4019-A68C-B7D351E72A7DQ26828930-0904D38A-42D4-4C13-BD83-9BB35BFFD78FQ26851160-C0F0B273-D40C-4F2B-A78E-7C27F0F16900Q27021470-2EE294DD-4A9A-483E-BB90-E53ED5BDE23AQ27025007-2678F3D2-1D6F-4839-9BE3-BDF01DCE4057Q27310114-0FF7305B-3866-4478-ABD9-0FAA2BA3C82BQ27330382-95B97AFD-507E-459C-B4E3-BEA0935EE4A9Q27332331-9A9F1394-346C-4555-B532-622154E3A68EQ28068259-6F68D270-85A9-4BC7-A775-9F7C69F6388DQ28068654-EBF7F7D7-5072-4430-837B-A95B52465EF4Q28084420-37E3ED09-B175-43D7-A6A4-3D378AA90CCBQ28393814-5328F04A-F517-49D5-8E3B-892403C21B9CQ28608269-0824B1EA-E0A1-4A94-96E5-520F49424F36Q30399006-6A3EFD89-D92E-4F1E-A5AA-D5FCD62B6D2DQ30454883-9A755F70-24ED-4550-B55A-B07EDEEEF774Q30525290-2A726683-3751-4C23-BEF3-A59444A62C05Q30542073-04692319-F657-4DAF-827F-2C33782A23B0Q30544603-7523BAD4-4AE2-4CCE-8F4B-E3FB78B0BAF6Q30651792-C9494EA9-43CF-4516-A808-E2C0AFA55FF2Q30708866-E8B7C533-8941-4CB7-A347-4A235D4AE4FEQ30731774-92676A68-09B8-4B4D-AED5-3EA6B3386077Q30764736-07CE5B84-D1FD-47B8-922B-CCD1C0742D39Q30847284-EB2ABA03-BD73-4137-B52F-3D3AB1C99AC7Q30938805-2F90D061-AB81-493C-868B-4012C61125A1Q33577008-94B31FCD-5E56-4C4B-B27F-7F60C64E8799Q33942378-2BDA8807-DA30-4954-AB51-964D1F57AFB0Q34081980-C1E99E3F-9966-4EB8-AD36-43A028281252Q34249349-CD37FDD9-E323-4483-AC75-4D0FECBB8973Q34598895-9A31726B-5263-41D8-8348-A876025BA2B6Q34662536-B0BAE855-4341-4935-A250-711325EE1ECEQ34807753-4A5CD13A-4115-49A0-9210-DDD9287EBF98Q35071819-6F9E458A-D0D0-433D-BA4F-35DB501AF66AQ35093286-B22A2CEA-C101-46A2-8824-D4C12A617D87Q35104052-A248070A-4DD3-484C-AB60-1A295468133DQ35133246-9A141E49-E7E8-4441-8E92-B21532AC99E8Q35157184-39D1DFF0-1512-4E6C-926D-0E4F505DB00E
P2860
Increased survival of glioblastoma patients who respond to antiangiogenic therapy with elevated blood perfusion.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Increased survival of glioblas ...... with elevated blood perfusion.
@ast
Increased survival of glioblas ...... with elevated blood perfusion.
@en
type
label
Increased survival of glioblas ...... with elevated blood perfusion.
@ast
Increased survival of glioblas ...... with elevated blood perfusion.
@en
prefLabel
Increased survival of glioblas ...... with elevated blood perfusion.
@ast
Increased survival of glioblas ...... with elevated blood perfusion.
@en
P2093
P2860
P1433
P1476
Increased survival of glioblas ...... with elevated blood perfusion
@en
P2093
A Gregory Sorensen
Dominique Jennings
Heisoog Kim
Marek Ancukiewicz
Meiyun Wang
Patrick Y Wen
Pavlina Polaskova
Rakesh K Jain
Tracy T Batchelor
P2860
P304
P356
10.1158/0008-5472.CAN-11-2464
P407
P577
2011-11-29T00:00:00Z